Aug 26, 2026 9:17 am EDT VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
Aug 26, 2026 8:17 am EDT Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis
